HOOKIPA PHARMA INC. Cash and Restricted Cash
HOOKIPA PHARMA INC. had Cash and Restricted Cash of $40.48 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-05-15
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40.48M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.89M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.96M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-03-31 | $40.48M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $39.89M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $59.96M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $77.35M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $92.95M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $117.52M 10-Q · filed 2025-05-15 |
| 2023-09-30 | $108.09M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $136.01M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $110.02M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $113.44M 10-K · filed 2025-02-28 |
| 2022-09-30 | $100.68M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $118.86M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $141.80M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $66.91M 10-K · filed 2025-02-28 |
| 2021-09-30 | $82.70M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $102.95M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $128.15M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $143.18M 10-K · filed 2024-03-22 |
| 2020-09-30 | $82.26M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $93.28M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $104.88M 10-Q · filed 2021-05-12 |
| 2019-12-31 | $113.58M 10-K · filed 2023-03-15 |
| 2019-09-30 | $124.01M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $135.21M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $70.51M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $48.58M 10-K · filed 2022-03-24 |
| 2018-09-30 | $55.79M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $63.36M 10-Q · filed 2019-08-12 |
| 2017-12-31 | $61.36M 10-K · filed 2021-03-18 |
| 2016-12-31 | $13.19M 10-K · filed 2020-03-19 |